High prevalence of low-trauma fracture in chronic pancreatitis

American Journal of Gastroenterology

Volumn 105, Issue 12, 2010, Pages 2680-2686

  Tignor, April S ^a   Wu, Bechien U ^a   Whitlock, Tom L ^a   Lopez, Rocio ^b   Repas, Kathryn ^a   Banks, Peter A ^a   Conwell, Darwin ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CHRONIC PANCREATITIS; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GASTRECTOMY; GASTROINTESTINAL DISEASE; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; INFANT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; VERTEBRA FRACTURE; WRIST FRACTURE;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; FRACTURES, BONE; FRACTURES, SPONTANEOUS; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; OSTEOPOROSIS; PANCREATITIS, CHRONIC; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78649844518     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.325     Document Type: Article

References (40)

1. National Osteoporosis Foundation. Physicians Guide to Prevention and Treatment of Osteoporosis. NOF: Washington, D.C, 1999. www.nof.org/ physguide accessed on 1 November 2008.
2. Raisz LG. Clinical practice. screening for osteoporosis. N Engl J Med 2005;353:164-71.
3. Bernstein CN, Leslie WD, LeBof MS. AGA technical review on osteo- porosis in gastrointestinal diseases. Gastroenterology 2003;124:795-841.
4. Leslie WD, Bernstein CN, Lebof MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003;125:941-66.
5. Williams SE, Seider DL. Metabolic bone disease in gastrointestinal illness. Gastroenterol Clin North Am 2007;36:161-90.
6. Van Staa TP, Cooper C, Brusse LS et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-7.
7. Payer J, Killinger Z, Aleryany S et al. Vitamin Ddeficiency as one of the causes of bone changes in CP. Vnitr Lek 1999;45:281-3.
8. Mann ST, Stracke H, Lange U et al. Vitamin D3 in patients with various grades of C P, according to morphological and functional criteria of the pancreas. Dig Dis Sci 2003;48:533-8.
9. Teichman J, Mann ST, Stracke H et al. Alterations of Vitamin D3 metabolism in young women with various grades of CP. Eur J Med Res 2007;12:347-50.
10. Moran CE, Sosa EG, Martinez SM et al. Bone mineral density in patients with pancreatic insufciency and steatorrhea. Am J Gastroenterol 1997;92:867-71.
11. Dujsikova H, Dite P, Tom L J et al. Occurrence of metabolic osteopathy in patients with CP. Pancreatology 2008;6:583-6.
12. Haabar AB, Rosenfalck AM, Hansen B et al.Bone mineral metabolism, bone mineral density, and body composition in patients with CP and pancreatic exocrine insufciency. Int J Pancreatol 2000;27:21-7.
13. Mann ST, Stracke H, Lange U et al. Alterations of bone mineral density and bone metabolism in patients with various grades of CP. Metabolism 2003;52:579-85.
14. Mann ST, Mann V, Stracke H et al. Fecal elastase 1 and Vitamin D3 in patients with osteoporotic fractures. Eur J Med Res 2008;3:68-72.
15. Lips P. Epidemiology and Predictors of fractures associated with osteoporosis. Am J Med 1997;103:8S-11S.
16. RPDR website. http://www.partners.org/rescomputing/template.asp?page-Id= 99&ArticleTitle=RPDR&level1ID=9&tocID=9&articleSubPage=true accessed on 11 February 2009.
17. Gage BF, Birman-Deych E, Radford M et al. Risk of osteoporotic fracture in elderly patients taking warfarin. Arch Intern Med 2006;166:241-6.
18. Triant V, Brown T, Lee H et al. Fracture prevalence among human immuno-def ciency virus (HIV)-infected versus non-HIV infected patients in a large US Healthcare System. J Clin Endocrinol Metab 2008;93:3499-504.
19. Schneider A, Lohr JM, Singer M. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007;42:101-19.
20. Bernstein CN, Leslie WD. Tepathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 2003;15:857-64.
21. Tilg H, Moschen AR, Kaser A et al. Gut, inf ammation and osteoporosis: basic and clinical concepts. Gut 2008;57:684-94.
22. Talukar R, Tandon RK. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol 2008;23:34-41.
23. Masamune A, Kikuta K, Satoh K et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 2009;58:550-9.
24. Bernstein CN, Blanchard JF, Leslie W et al. The incidence of fracture among patients with inf ammatory bowel disease. A population-based cohort study. Ann Intern Med 2000;133:795-9.
25. Bernstein CN, Blanchard JF, Rawsthorne P et al.EpidemiologyofCrohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-24.
26. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002;156:1-10.
27. Vestergaard P, Krogh K, Rejnmark L et al. Fracture risk is increased in Crohn's disease, but not ulcerative colitis. Gut 2000;46:176-81.
28. Jafri MR, Nordstrom CW, Murray JA. Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci 2008;53:964-71.
29. Vasquez H, Mazure R, Gonzalez D. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol 2000;95:183-9.
30. LofusEV Jr, Crowsn CS, Sandborn WJ. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 2002;123:468-75.
31. Motley RJ, Clements D, Evans WD et al. A four-year longitudinal study of bone loss in patients with inf ammatory bowel disease. Bone Miner 1993;23:95-104.
32. Abitol V, Roux C, Chassade S et al. Metabolic bone assessment in patients with inf ammatory bowel disease. Gastroenterology 1995;108:417-22.
33. Schoon EJ, Van Nunen AB, Wouters RSM E et al.Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol 2000;35:43-7.
34. Jahnsen J, Falch JA, Aadland E et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-9.
35. Fickling WE, McFarlane XA, Bhalla AK et al.Teclinical impact of metabolic bone disease in celiac disease. Postgrad Med J 2001;77:33-6.
36. Olsson R, Johansson C, Lindstedt G et al. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol 1994;29:753-6.
37. Stellon AJ, Davies A, Compston J et al. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy. Gastroenterology 1985;89:1078-83.
38. Liberman UA, Weills SR, Broll J et al. Effect of oral Alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Eng J Med 1995;333:1437-43.
39. Cauley JA, Lui LY, Ensrud KE. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA 2005;293:2102-8.
40. Jencks SF. Accuracy in recorded diagnoses. [Editorial]. JAMA 1992;267:2238-9.